<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03116217</url>
  </required_header>
  <id_info>
    <org_study_id>16/8805</org_study_id>
    <secondary_id>2016-A01914-47</secondary_id>
    <nct_id>NCT03116217</nct_id>
  </id_info>
  <brief_title>Validation of a Fetal Urine Peptidome-based Classifier to Predict Post-natal Renal Function in Posterior Urethral Valves</brief_title>
  <acronym>Antenatal</acronym>
  <official_title>Multicentre Validation of a Fetal Urine Peptidome-based Classifier to Predict Post-natal Renal Function in Posterior Urethral Valves</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Validate the use of fetal urine peptidome-analysis for the stratification of fetuses with
      Posterior Urethral Valve for post-natal renal function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ANTENATAL project requires the use of fetal urine as well as post-natal urine, post-natal
      serum and, possibly, amniotic liquid. We will take an additional tube during the takings
      collected for routine management of the disease.

      The analysis of samples will be carried out in Toulouse at the Institute of Metabolic and
      Cardiovascular Diseases or with fee-for-service suppliers.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 26, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Renal/patient survival at 2 years post-natally.</measure>
    <time_frame>Year 2</time_frame>
    <description>Defined by the need for dialysis or death.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Renal function of the survivors at day 4 and 6 and 12 month post-natally.</measure>
    <time_frame>Year 1</time_frame>
    <description>This post-natal renal function, estimated via serum cystatin C concentrations, will be analysed centrally in Toulouse to homogenise the analysis.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Posterior Urethral Valve</condition>
  <arm_group>
    <arm_group_label>Posterior Urethral Valves</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fetuses with suspected Posterior Urethral Valves</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fetuses with suspected Posterior Urethral Valves</intervention_name>
    <description>Fetal urine, post-natal urine, post-natal serum and, possibly, amniotic liquid analysis.</description>
    <arm_group_label>Posterior Urethral Valves</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male singleton fetus with megabladder associated with urinary tract anomalies with or
             without dysplastic or hyperechogenic parenchyma detected in a first ultrasound;

          -  megabladder confirmed in a second ultrasound;

          -  collection of fetal urine taken during the routine management of the disease for the
             dosage of ß2-microglobulin;

          -  written informed consent.

        Exclusion Criteria:

          -  refusal to participate in the study;

          -  person protected by law.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stéphane DECRAMER, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stéphane DECRAMER, Pr</last_name>
    <phone>5 34 55 84 58</phone>
    <phone_ext>33</phone_ext>
    <email>decramer.s@chu-toulouse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Françoise CONTE-AURIOL</last_name>
    <email>auriol.f@chu-toulouse.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>An Hindryckx</last_name>
      <phone>16341729</phone>
      <phone_ext>32</phone_ext>
      <email>an.hindryckx@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>An Hindryckx</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luc De Catte</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Pellegrin-Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33078</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHRU de Brest - Hôpital Morvan</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Femme Mère Enfant-Lyon</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CH René-Dubos</name>
      <address>
        <city>Cergy Pontoise</city>
        <zip>95303</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Estaing</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Helene LAURICHESSE, Dr</last_name>
      <phone>4 73 75 01 56</phone>
      <phone_ext>33</phone_ext>
      <email>helaurichesse@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Helene LAURICHESSE, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>D. GALLOT, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lucie BESSENAY, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble - Hôpital Couple-Enfant - Département de la Génétique</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de la Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital mère-enfant pédiatrie</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norbert WINER, Dr</last_name>
      <phone>2 40 08 31 76</phone>
      <phone_ext>33</phone_ext>
      <email>norbert.winer@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Norbert WINER, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emma ALLAIN-LAUNEY, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Lenval</name>
      <address>
        <city>Nice</city>
        <zip>06200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elizabeth SIMON, Dr</last_name>
      <phone>4 92 03 08 09</phone>
      <phone_ext>33</phone_ext>
      <email>Elisabeth.SIMON@lenval.com</email>
    </contact>
    <investigator>
      <last_name>Elizabeth SIMON, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean BREAUD, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AP-HP - Hôpital Necker Enfants malades</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yves VILLE, Pr</last_name>
      <phone>1 71 39 65 01</phone>
      <phone_ext>33</phone_ext>
      <email>yves.ville@nck.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Yves VILLE, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas BLANC, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurence HEIDET, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Robert-Debré</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jonathan ROSENBLATT, Dr</last_name>
      <phone>1 40 03 47 15</phone>
      <phone_ext>33</phone_ext>
      <email>jonathan.rosenblatt@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Jonathan ROSENBLATT, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Véronique BAUDOIN, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Georges DESCHENES, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Rennes Hôpital Sud</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Hôpitaux de St-Etienne-Hôpital Nord</name>
      <address>
        <city>Saint Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier universitaire Chu Amiens Salouël Hôpital sud</name>
      <address>
        <city>Salouel</city>
        <zip>80480</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sihcus-Cmco</name>
      <address>
        <city>Schiltigheim</city>
        <zip>67300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Romain FAVRE, Pr</last_name>
      <phone>3 69 55 34 44</phone>
      <phone_ext>33</phone_ext>
      <email>romain.favre@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Romain FAVRE, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raphael MOOG, Chirurgien</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Bagatelle (Talence) - CHU Pellegrin (Bordeaux)</name>
      <address>
        <city>Talence</city>
        <zip>33400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne PARIS, Dr</last_name>
      <phone>5 57 12 36 54</phone>
      <phone_ext>33</phone_ext>
      <email>a.paris@mspb.com</email>
    </contact>
    <investigator>
      <last_name>Anne PARIS, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric DOBREMEZ, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-Françoise FROUTE, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Paule de Viguier-Hôpital des enfants- Site Purpan</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphane Decramer, Pr</last_name>
      <phone>5 34 55 86 64</phone>
      <phone_ext>33</phone_ext>
      <email>decramer.s@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Stéphane DECRAMER, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christophe VAYSSIERES, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Agnès SARTOR, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Olympe de Gouges du CHRU de Tours</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Franck PERROTIN, Pr</last_name>
      <phone>2 47 47 47 39</phone>
      <phone_ext>33</phone_ext>
      <email>f.perrotin@chu-tours.fr</email>
    </contact>
    <investigator>
      <last_name>Franck PERROTIN, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sylvie CLOAREC, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heidelberg University Hospital</name>
      <address>
        <city>Heidelberg</city>
        <zip>60120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Franz Schaefer</last_name>
      <phone>6221-56-32396</phone>
      <phone_ext>49</phone_ext>
      <email>franz.schaefer@med.uni-heidelberg.de</email>
    </contact>
    <investigator>
      <last_name>Franz Schaefer</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Elsässer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicola Persico</last_name>
      <phone>328 5433367</phone>
      <phone_ext>39</phone_ext>
      <email>nicola.persico@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Nicola Persico</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gianantonio Manzoni</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giovanni Montini</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Leiden University Medical Center Dept of prenatal diagnosis and therapy</name>
      <address>
        <city>Leiden</city>
        <state>The Netherlands</state>
        <zip>2333</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dick Oepkes</last_name>
      <phone>71 5262896</phone>
      <phone_ext>31</phone_ext>
      <email>d.oepkes@lumc.nl</email>
    </contact>
    <investigator>
      <last_name>Dick Oepkes</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Phebe Adama van Scheltema</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Radboudumc Amalia Children's Hospital</name>
      <address>
        <city>Nijmegen</city>
        <state>The Netherlands</state>
        <zip>6500</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wout Feitz, Pr</last_name>
      <phone>243613735</phone>
      <phone_ext>31</phone_ext>
      <email>wout.feitz@radboudumc.nl</email>
    </contact>
    <investigator>
      <last_name>Wout Feitz, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Barbara Kortmann, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michiel Schreuder, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frank Vandenbussche, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Polish Mothers Memorial Hospital Research Institute</name>
      <address>
        <city>Lodz</city>
        <zip>93-338</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marcin Tkaczyk, Pr</last_name>
      <phone>42 2711391</phone>
      <phone_ext>48</phone_ext>
      <email>mtkaczyk@uni.lodz.pl</email>
    </contact>
    <investigator>
      <last_name>Marcin Tkaczyk, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Krzysztof Szaflik, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Justyna Wojtera, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Małgorzata Stańczyk, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tomasz Talar, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Barbara Pawłowska, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jerzy Guzowski, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dariusz Olejniczak, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sławomir Chrul, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gema Ariceta</last_name>
      <phone>934893082</phone>
      <phone_ext>34</phone_ext>
      <email>gariceta@vhebron.net</email>
    </contact>
    <investigator>
      <last_name>Gema Ariceta</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elena Carreras</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Silvia Arevalo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carlota Rodo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital des Enfants Hôpitaux universitaire Genève (HUG)</name>
      <address>
        <city>Geneve</city>
        <state>Switserland</state>
        <zip>CH-1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paloma Parvex, Pr</last_name>
      <phone>22795532596</phone>
      <phone_ext>41</phone_ext>
      <email>paloma.parvex@hcuge.ch</email>
    </contact>
    <investigator>
      <last_name>Paloma Pervex, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jaques Birraux, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gianmaria Pellegrinelli, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hassib Chehade, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>FetalMedicine Centre Birmingham Women's Hospital</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2TG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Katie Morris, Dr</last_name>
      <phone>121 627 6652</phone>
      <phone_ext>44</phone_ext>
      <email>r.k.morris@bham.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Katie Morris, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark David Kilby, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Hogan J, Dourthe ME, Blondiaux E, Jouannic JM, Garel C, Ulinski T. Renal outcome in children with antenatal diagnosis of severe CAKUT. Pediatr Nephrol. 2012 Mar;27(3):497-502. doi: 10.1007/s00467-011-2068-6. Epub 2011 Dec 14.</citation>
    <PMID>22167562</PMID>
  </reference>
  <reference>
    <citation>Seeds JW. Diagnostic mid trimester amniocentesis: how safe? Am J Obstet Gynecol. 2004 Aug;191(2):607-15. Review.</citation>
    <PMID>15343248</PMID>
  </reference>
  <reference>
    <citation>Clark TJ, Martin WL, Divakaran TG, Whittle MJ, Kilby MD, Khan KS. Prenatal bladder drainage in the management of fetal lower urinary tract obstruction: a systematic review and meta-analysis. Obstet Gynecol. 2003 Aug;102(2):367-82. Review.</citation>
    <PMID>12907115</PMID>
  </reference>
  <reference>
    <citation>Morris RK, Malin GL, Quinlan-Jones E, Middleton LJ, Hemming K, Burke D, Daniels JP, Khan KS, Deeks J, Kilby MD; Percutaneous vesicoamniotic shunting in Lower Urinary Tract Obstruction (PLUTO) Collaborative Group. Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial. Lancet. 2013 Nov 2;382(9903):1496-506. doi: 10.1016/S0140-6736(13)60992-7. Epub 2013 Aug 14.</citation>
    <PMID>23953766</PMID>
  </reference>
  <reference>
    <citation>Schmoor C, Sauerbrei W, Schumacher M. Sample size considerations for the evaluation of prognostic factors in survival analysis. Stat Med. 2000 Feb 29;19(4):441-52.</citation>
    <PMID>10694729</PMID>
  </reference>
  <reference>
    <citation>Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, Bossuyt PM. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA. 1999 Sep 15;282(11):1061-6. Erratum in: JAMA 2000 Apr 19;283(15):1963.</citation>
    <PMID>10493205</PMID>
  </reference>
  <reference>
    <citation>Rutjes AW, Reitsma JB, Di Nisio M, Smidt N, van Rijn JC, Bossuyt PM. Evidence of bias and variation in diagnostic accuracy studies. CMAJ. 2006 Feb 14;174(4):469-76.</citation>
    <PMID>16477057</PMID>
  </reference>
  <reference>
    <citation>Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006 Oct;59(10):1087-91. Epub 2006 Jul 11. Review.</citation>
    <PMID>16980149</PMID>
  </reference>
  <reference>
    <citation>Klein J, Lacroix C, Caubet C, Siwy J, Zürbig P, Dakna M, Muller F, Breuil B, Stalmach A, Mullen W, Mischak H, Bandin F, Monsarrat B, Bascands JL, Decramer S, Schanstra JP. Fetal urinary peptides to predict postnatal outcome of renal disease in fetuses with posterior urethral valves (PUV). Sci Transl Med. 2013 Aug 14;5(198):198ra106. doi: 10.1126/scitranslmed.3005807.</citation>
    <PMID>23946195</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 10, 2017</study_first_submitted>
  <study_first_submitted_qc>April 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2017</study_first_posted>
  <last_update_submitted>October 31, 2017</last_update_submitted>
  <last_update_submitted_qc>October 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>renal function</keyword>
  <keyword>post natal</keyword>
  <keyword>peptidome</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

